Special Interest Sessions
Special Interest sessions provide the opportunity for ASH’s various communities to focus on specific topics of interest, ranging from coping with physician stress and burnout, to counseling fellows on careers in hematology, to the impact of ASH’s international outreach programs.
Unless otherwise noted, all sessions will take place in person and stream simultaneously on the virtual platform. Session recordings will be available on demand on the virtual platform.
Artificial Intelligence in Hematology: From Generative AI to Ethics and Applications
Saturday, DecemberÌý7,Ìý2024,Ìý4:00Ìýp.m.Ìý-Ìý5:30Ìýp.m.
San Diego Convention Center, Hall B
The session will address important and timely topics related to the application of artificial intelligence (AI) to hematology, ranging from generative AI's potential and pitfalls, modern ethical consideration for AI in biomedical research and examples of practical use of AI in hematology research and clinical care.
Chair:
°¿±ô¾±±¹¾±±ð°ùÌý·¡±ô±ð³¾±ð²Ô³Ù´Ç,Ìý±Ê³ó¶Ù,²Ñ³§,µþ³§
Weill Cornell Medicine
New York,ÌýNY
Speakers:
´³²¹³¾±ð²õÌý´Ü´Ç³Ü,Ìý±Ê³ó¶Ù
Stanford University
³§³Ù²¹²Ô´Ú´Ç°ù»å,Ìý°ä´¡
The Potential and Pitfalls of Generative AI in Basic and Clinical Research
°ä²¹³¾¾±±ô±ô±ðÌý±·±ð²ú±ð°ì±ð°ù,Ìý·¡»å¶Ù
University of California San Diego
San Diego,ÌýCA
From Principles to Practice: Ensuring Ethical Integrity in AI-Driven Biomedical Research
°ä±ô²¹³Ü»å¾±²¹Ìý±á²¹´Ú±ð°ù±ô²¹³¦³ó,Ìý²Ñ¶Ù
MLL Munich Leukemia Laboratory
²Ñ³Ü²Ô¾±³¦³ó,Ìý³Ò±ð°ù³¾²¹²Ô²â
The Application of Artificial Intelligence in Hematological Diagnostics
ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults
Sunday, DecemberÌý8,Ìý2024,Ìý9:30Ìýa.m.Ìý-Ìý11:00Ìýa.m.
Marriott Marquis San Diego Marina, Marriott Grand Ballroom 2-4
This special education session will preview recommendations for the management of both newly diagnosed and relapsed/refractory ALL in adolescents and young adults.
Chair:
SumitÌýGupta,ÌýMD, PhD
Hospital for Sick Children
°Õ´Ç°ù´Ç²Ô³Ù´Ç,Ìý°¿±·,Ìý°ä²¹²Ô²¹»å²¹
Speakers:
JulieÌýWolfson,ÌýMD, MSHS
The University of Alabama at Birmingham
µþ¾±°ù³¾¾±²Ô²µ³ó²¹³¾,Ìý´¡³¢
Management of Frontline ALL in AYA
Jennifer L.ÌýMcNeer,ÌýMD
University of Utah/Primary Children's Hospital
Salt Lake City,ÌýUT
Management of Frontline ALL in AYA
Kristen M.ÌýO'Dwyer,ÌýMD
University of Rochester
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý±·³Û
Management of Refractory and Relapse of ALL in Adolescents and Young Adults
Lena EÌýWinestone,ÌýMD
University of California San Francisco
San Francisco,ÌýCA
Management of Refractory and Relapse of ALL in Adolescents and Young Adults
ASH Clinical Practice Guidelines on Amyloidosis
Sunday, DecemberÌý8,Ìý2024,Ìý4:30Ìýp.m.Ìý-Ìý6:00Ìýp.m.
Manchester Grand Hyatt San Diego, Grand Hall B
This session will review the scope and goals of the upcoming guidelines on amyloidosis, and will provide insights on risk factors, selecting a target site versus a surrogate site for diagnostic biopsies, and using Congo Red stain screening.
Chair:
³Õ¾±²õ³ó²¹±ôÌý°³Ü°ì°ù±ð³Ù¾±,Ìý²Ñ¶Ù,²Ñ³§³¦
Princess Margaret Cancer Centre
°Õ´Ç°ù´Ç²Ô³Ù´Ç,Ìý°¿±·,Ìý°ä²¹²Ô²¹»å²¹
Speakers:
´³´Ç²õ±ð±ô±ô±ðÌý°ä´Ç´Ç°ì,Ìý²Ñµþµþ³§
Mayo
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Increasing Awareness of Risk Factors for AL Amyloidosis
´¡²Ô²µ±ð±ô²¹Ìý¶Ù¾±²õ±è±ð²Ô³ú¾±±ð°ù¾±,Ìý²Ñ¶Ù
Mayo Clinic
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Target Site vs. Surrogate Site Biopsy for Diagnosis
±á¾±°ù²¹Ìý³§³ó²¹¾±°ì³ó,Ìý²Ñ¶Ù
University of Iowa Caver College of Medicine
°ä´Ç°ù²¹±ô±¹¾±±ô±ô±ð,Ìý±õ´¡
Target Site Vs. Surrogate Site Biopsy for Diagnosis
±·²¹°ù±ð²õ³óÌýµþ³Ü³¾³¾²¹,Ìý²Ñ¶Ù
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Congo Red Stain Bone Marrow Screening for AL Amyloidosis
ASH Clinical Practice Guidelines on Pediatric Venous Thromboembolism (VTE)
Saturday, DecemberÌý7,Ìý2024,Ìý9:30Ìýa.m.Ìý-Ìý11:00Ìýa.m.
San Diego Convention Center, Room 25
This special education session will give a preview on the revision background, which includes asymptomatic VTE, duration of therapy for provoked and unprovoked VTE, and use of anticoagulants (especially DOACs) in pediatric patients.
Chair:
±Ê²¹³Ü±ôÌý²Ñ´Ç²Ô²¹²µ±ô±ð,Ìý²Ñ¶Ù,µþ³§,²Ñ³§³¦,¹ó¸é´¡°ä±Ê,¹ó¸é°ä±Ê´¡,²Ñµþ
University of Melbourne Royal Children's Hospital
±Ê²¹°ù°ì±¹¾±±ô±ô±ð,Ìý³Õ±õ°ä,Ìý´¡³Ü²õ³Ù°ù²¹±ô¾±²¹
Speakers:
³¢±ð²õ±ô¾±±ðÌý¸é²¹´Ú´Ú¾±²Ô¾±,Ìý²Ñ¶Ù
Children's Hospital of Philadelphia
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Why Revise the Guidelines?
¸é³Ü°ì³ó³¾¾±Ìýµþ³ó²¹³Ù,Ìý²Ñ¶Ù,²Ñ³§
Lurie Children's Hospital
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
Asymptomatic VTE in Pediatric Patients
²Ñ²¹°ù¾±²õ´Ç±ôÌýµþ±ð³Ù±ð²Ô²õ°ì²â,Ìý²Ñ¶Ù,²Ñ±Ê±á
Johns Hopkins All Children's Hospital
Saint Petersburg,ÌýFL
Duration of Therapy for Provoked and Unprovoked VTE in Pediatric Patients
°Õ¾±²Ô²¹Ìýµþ¾±²õ²õ
The Newcastle upon Tyne Hospitals NHS Trust
Newcastle Upon Tyne,ÌýENG,ÌýUnited Kingdom
Use of Anticoagulants in Children
ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly
Sunday, DecemberÌý8,Ìý2024,Ìý11:15Ìýa.m.Ìý-Ìý12:30Ìýp.m.
Marriott Marquis San Diego Marina, Marina Ballroom DE
Artificial Intelligence (AI) has the potential to transform health care by enhancing diagnostic accuracy, predicting patient outcomes, and developing personalized treatment plans. Machine learning algorithms can analyze vast amounts of medical data, leading to more efficient and precise health care interventions, which could improve patient care and reduce costs. However, implementation of AI in health care also poses challenges related to data privacy concerns, ethical considerations, and the need for robust regulatory frameworks to ensure the responsible and secure use of sensitive medical information. In this session, panelists will speak on the recent advances and use of AI in health care, how it’s integrated into hematology practice by providers, and the use of AI by patients.
Chair:
Mary-Elizabeth M.ÌýPercival,ÌýMD
Seattle Cancer Care Alliance
³§±ð²¹³Ù³Ù±ô±ð,Ìý°Â´¡
Speakers:
JimÌýWhitfill,ÌýMD MBA FACP FSIIM
HonorHealth
±Ê³ó´Ç±ð²Ô¾±³æ,Ìý´¡´Ü
Artificial Intelligence in Health Care: Benefits and Pitfalls
ChristopherÌýManz,ÌýMD, MSHP
Dana-Farber Cancer Institute
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Artificial Intelligence as a Clinical Tool: Hacks in Practice
Gwen LÌýNichols,ÌýMD
The Leukemia and Lymphoma Society
Rye Brook,ÌýNY
Patient Facing Artificial Intelligence: Uses and Ethical Implications
ASH Networking Reception for the Hemostasis and Thrombosis Community - Hosted by the Blood Vessels, Thrombosis and Hemostasis Journal
Monday, DecemberÌý9,Ìý2024,Ìý6:00Ìýp.m.Ìý-Ìý7:30Ìýp.m.
San Diego Convention Center, East Terrace (Upper Level)
ASH Quality Improvement Champions
Monday, DecemberÌý9,Ìý2024,Ìý2:45Ìýp.m.Ìý-Ìý4:15Ìýp.m.
San Diego Convention Center, Room 7
This new session merges the ASH Choosing Wisely Champions and the ASH Guideline Implementation Champions into a single, 90-minute session. Speakers will be selected from a pool of applicants. In addition to projects that combat overuse (previously the focus of the Choosing Wisely Champions session) and projects that highlight successful guideline implementation strategies (previously the focus of the Guideline Implementation Champions session), the call for applications for this session considers any quality improvement project (e.g., combating underuse, improving stewardship of resources, improving processes, reducing or eliminating healthcare disparities, etc.). The goal of this change is to expand opportunities to highlight high-quality quality improvement work while concentrating the focus into a single session.
Co-Chairs:
Ming YÌýLim,ÌýMBBChir
University of Utah Health
Salt Lake Cty,ÌýUT
Rachel P.ÌýRosovsky,ÌýMD
Massachusetts General Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Speakers:
JosauraÌýFernandez Sanchez,ÌýMD
Texas Children’s Hospital, Baylor College of Medicine
±á´Ç³Ü²õ³Ù´Ç²Ô,Ìý°Õ³Ý
Standardizing Emergency Department Management of Iron Deficiency Anemia from Heavy Menstrual Bleeding
±Ê²¹´Ç±ô´ÇÌý³¢´Ç±è±ð»å´Ç³Ù±ð,Ìý²Ñ¶Ù
City of Hope National Medical Center
²Ñ´Ç²Ô°ù´Ç±¹¾±²¹,Ìý°ä´¡
Reduced Blood Transfusions in Patients with Chronic Liver Disease Undergoing Paracentesis
Asinamai MÌýNdai,ÌýBPharm, MS
University of Florida Health Physicians
³Ò²¹¾±²Ô±ð²õ±¹¾±±ô±ô±ð,Ìý¹ó³¢
Optimized Management of Hemophilia in the Emergency Department
91¹ú²ú¾«Æ· Collaborative Data Hub Sickle Cell Disease Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
Monday, DecemberÌý9,Ìý2024,Ìý4:30Ìýp.m.Ìý-Ìý6:00Ìýp.m.
San Diego Convention Center, Room 11
During this 90-minute special-interest session, sickle cell disease (SCD) registry and real-world evidence (RWE) leaders will discuss progress across numerous SCD data initiatives, including the 91¹ú²ú¾«Æ· Collaborative's SCD Data Hub and other federal and non-federal programs. Specific topics include examples of using real-world data (RWD) to generate RWE, how RWD can be used to monitor clinical practice and outcomes for patients who receive cell and gene therapies, various approaches to ensuring data quality when using electronic health record data (EHR), federal priorities related to RWE generation that supports regulated research, and a new project to increase SCD-specific data standards with EHRs.
Co-Chairs:
AlexisÌýThompson,ÌýMD, MPH
Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
°Õ±ð»åÌý°Â³Ü²Ô,Ìý²Ñ¶Ù
Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center
³§²¹³¦°ù²¹³¾±ð²Ô³Ù´Ç,Ìý°ä´¡
Speakers:
AlexisÌýThompson,ÌýMD, MPH
Children's Hospital of Philadelphia
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Representing Sickle Cell Disease Health Concepts in Real World Evidence Generation: Examples from Real World Data (RWD) Initiatives and the Importance to the Sickle Cell Disease Community
±Ê²¹³Ù³Ù²âÌý³§³Ù±ð¾±²Ô±ð°ù³Ù,Ìý±Ê³ó¶Ù,²Ñµþ´¡
Medical College of Wisconsin
²Ñ¾±±ô·É²¹³Ü°ì±ð±ð,Ìý°Â±õ
The Role of RWD in Long-Term Follow-up of Cell and Gene Therapies in Sickle Cell Disease: The CIBMTR experience
³§´Ç±è³ó¾±±ðÌý³¢²¹²Ô³ú°ì°ù´Ç²Ô,Ìý²Ñ¶Ù
Thomas Jefferson University
µþ²¹±ô³Ù¾±³¾´Ç°ù±ð,Ìý²Ñ¶Ù
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (1)
´¡²õ³ó¾±³¾²¹Ìý³§¾±²Ô²µ³ó,Ìý±Ê³ó¶Ù,²Ñ³§
Medical College of Wisconsin
±Ê±ð·É²¹³Ü°ì±ð±ð,Ìý°Â±õ
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (2)
±·¾±³¦´Ç±ô±ðÌý³Õ±ð°ù»å³Ü²Ô,Ìý²Ñ¶Ù
FDA
Silver Spring,ÌýMD
Regulatory Perspective: Why RWD is Critical for Evaluation of SCD Disease Modifying Curative Therapies
LaVerneÌýPerlie,ÌýMSN, RN
Health and Human Services Assistant Secretary for Technology Policy
°Â²¹²õ³ó¾±²Ô²µ³Ù´Ç²Ô,Ìý¶Ù°ä
Bringing It All Together: How the Federal Government Is Facilitating Collaboration across the Sickle Cell Data Landscape
91¹ú²ú¾«Æ· Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
Saturday, DecemberÌý7,Ìý2024,Ìý4:00Ìýp.m.Ìý-Ìý5:30Ìýp.m.
Marriott Marquis San Diego Marina, Pacific Ballroom Salons 24-26
This 90-minute special-interest session will focus on the 91¹ú²ú¾«Æ· Collaborative’s Multiple Myeloma Program’s efforts to accelerate research and collaborative clinical care in hematologic malignancies. Three topics will describe the 91¹ú²ú¾«Æ· Collaborative’s approach to aggregating and visualizing real-world data (RWD) in multiple myeloma in a US-based, multi-site network; a proof-of-concept study with a hybrid decentralized workflow that was conducted in the ASH RC Myeloma Network this year; and new directions for RWD analysis in hematologic malignancies, including the use of artificial intelligence. A panel will then highlight work that is being done by the European HARMONY Alliance and other real-world data registries.
Chair:
Kenneth C.ÌýAnderson,ÌýMD
Dana-Farber Cancer Institute
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Speakers:
William A.ÌýWood,ÌýMD,MPH
University of North Carolina At Chapel Hill Hospital
Chapel Hill,ÌýNC
Building a National Multiple Myeloma Data Hub to Accelerate Research and Enhance Clinical Care
Saad Z.ÌýUsmani,ÌýMD
Memorial Sloan Kettering Cancer Center
New York,ÌýNY
Working with Data Hub Data and Network PIs to Develop Evidence that Changes Practice in Multiple Myeloma: The COSMIC Study as Proof of Concept
³§³ó²¹Âá¾±Ìý°³Ü³¾²¹°ù,Ìý²Ñ¶Ù
Mayo Clinic
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Pushing Data Frontiers: How Artificial Intelligence and Molecular Data can Facilitate Translational Research in the Network
Jesus MariaÌýHernandez Rivas,ÌýMD
University of Salamanca, IBSAL, IBMCC, CSIC
³§²¹±ô²¹³¾²¹²Ô³¦²¹,Ìý³§±è²¹¾±²Ô
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 1)
·¡±ô±ð²Ô²¹Ìý´Ü²¹³¾²¹²µ²Ô¾±,Ìý²Ñ¶Ù
Bologna University School of Medicine
µþ´Ç±ô´Ç²µ²Ô²¹,Ìý±õ³Ù²¹±ô²â
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 2)
Doris K.ÌýHansen,ÌýMD
H. Lee Moffitt Cancer Center and Research Institute
°Õ²¹³¾±è²¹,Ìý¹ó³¢
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 3)
ASH-FDA Joint Symposium I
Monday, DecemberÌý9,Ìý2024,Ìý10:30Ìýa.m.Ìý-Ìý12:00Ìýp.m.
San Diego Convention Center, Room 11
Chair:
Donna A.ÌýWhyte-Stewart,ÌýMD,MSc
Johns Hopkins School of Medicine
Silver Spring,ÌýMD
ASH-FDA Joint Symposium II
Monday, DecemberÌý9,Ìý2024,Ìý4:30Ìýp.m.Ìý-Ìý6:00Ìýp.m.
San Diego Convention Center, Room 7
Blood Advances Presents: How to Peer Review a Scientific Paper
Sunday, DecemberÌý8,Ìý2024,Ìý11:15Ìýa.m.Ìý-Ìý12:15Ìýp.m.
San Diego Convention Center, Room 24
Peer review plays a vital role in the dissemination and assessment of scientific research. Authors benefit from receiving an independent assessment of their work and reviewers benefit by gaining access to novel data. Dr. Catherine Bollard and Dr. Andrew Weyrich, the editor-in-chief and deputy editor for Blood Advances, will present recommended practices for reviewing a scientific paper for a peer-reviewed journal. The session will include topics such as things to consider when accepting or declining an invitation to review, how to write a review that is helpful for authors and editors, and what a reviewer should do if they suspect a possible research integrity issue. The presentation will be followed by a period for audience questions.
Panelist:
Andrew S.ÌýWeyrich,ÌýPhD
Oklahoma Medical Research Foundation
Oklahoma City,ÌýOK
Blood Presents: How to Get Published in a Peer-Reviewed Journal
Saturday, DecemberÌý7,Ìý2024,Ìý11:15Ìýa.m.Ìý-Ìý12:15Ìýp.m.
San Diego Convention Center, Room 24
Peer-reviewed journals serve a crucial role in helping researchers refine and publicize their work and helping readers sort through the ever-expanding scientific literature. Yet finding the right journal for one's research and framing data properly can be a challenge. Dr. Nancy Berliner and Dr. Andrew Roberts, the editor-in-chief and deputy editor for Blood, will present recommended practices for writing a scientific paper and submitting it to a peer-reviewed journal. The session will include topics such as how to develop the "story" for your research, how to respond to reviewer comments, and what to do when your submission is rejected. The presentation will be followed by a period for audience questions.
Panelists:
±·²¹²Ô³¦²âÌýµþ±ð°ù±ô¾±²Ô±ð°ù,Ìý²Ñ¶Ù
Brigham and Women's Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Andrew W.ÌýRoberts,ÌýMBBS,PhD
The Walter and Eliza Hall Institute of Medical Research
±Ê²¹°ù°ì±¹¾±±ô±ô±ð,Ìý³Õ±õ°ä,Ìý´¡³Ü²õ³Ù°ù²¹±ô¾±²¹
Center for Sickle Cell Disease Initiatives: Advancing Progress in Sickle Cell Disease Update and Reception: hosted by ASH and 91¹ú²ú¾«Æ· Collaborative
Monday, DecemberÌý9,Ìý2024,Ìý6:00Ìýp.m.Ìý-Ìý8:00Ìýp.m.
San Diego Convention Center, Room 11 and West Terrace
All meeting attendees interested in sickle cell disease are invited to attend the Center for Sickle Cell Disease Initiatives: Advancing Progress in Sickle Cell Disease Update and Reception. ASH is continuing its keen focus on the sickle cell disease initiative through the newly established ASH Center for Sickle Cell Disease Initiatives. This new Center will bring greater focus and cohesion to advancing our SCD initiatives. The Center is enhancing our ability to coordinate, track, and manage the wide range of responsibilities for this strategic initiative. The Center is focused on: Convening multidisciplinary partners and collaborators, promoting access to high quality care, global issues, policy and advocacy, research, and leveraging data. Please join us for an evening of networking and learn about this year's accomplishments.
back to topClinical Care and Research Implications Following Voxelotor Withdrawal
Monday, DecemberÌý9,Ìý2024,Ìý10:30Ìýa.m.Ìý-Ìý12:00Ìýp.m.
San Diego Convention Center, Room 33
Chair:
John JÌýStrouse,ÌýMD, PhD
Duke University
¶Ù³Ü°ù³ó²¹³¾,Ìý±·°ä
Speakers:
John JÌýStrouse,ÌýMD, PhD
Duke University
¶Ù³Ü°ù³ó²¹³¾,Ìý±·°ä
Immediate Fall Out Post-Voxelotor Withdrawal
Maureen OkamÌýAchebe,ÌýMD,MPH
Hematology Division Brigham and Women's
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Implications for Ongoing Clinical Research in SCD and Drug Development
AlexisÌýThompson,ÌýMD, MPH
Perelman School of Medicine, University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Landscape of SCD Treatment Options and New Therapies
DEI Community Networking Lunch (for in-person participants)
Monday, DecemberÌý9,Ìý2024,Ìý12:00Ìýp.m.Ìý-Ìý1:15Ìýp.m.
Marriott Marquis San Diego Marina, Marina Ballroom D
This is a community-building and networking event for members that fall within the diversity, equity, and inclusion (DEI) umbrella to gather and get to know each other across the varying and intersectional communities. This event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create space for ASH DEI communities and allies and, where possible, identify opportunities to learn more about the experiences and needs of these communities to allow ASH to have a greater impact in its DEI efforts. This year’s event will include inspiring remarks from a member of the committee and networking opportunities throughout.
Moderators:
±·´Ç³ó²¹Ìý³§´Ç°ù´Ç°ù,Ìý²Ñ¶Ù,²Ñ³§³¦
University of Oklahoma Health Science Center
·¡»å³¾´Ç²Ô»å,Ìý°¿°
³§²¹°ù·É¾±²õ³óÌý¸é²¹´Ú¾±±ç,Ìý±Ê³ó¶Ù
Emory University School of Medicine
´¡³Ù±ô²¹²Ô³Ù²¹,Ìý³Ò´¡
Panelist:
MarcosÌýde Lima,ÌýMD
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Early Faculty Career Development Session
Monday, DecemberÌý9,Ìý2024,Ìý10:30Ìýa.m.Ìý-Ìý12:00Ìýp.m.
San Diego Convention Center, Room 25
In this Junior Faculty Career Development Session, attendees will hear a series of lectures focused on Mentorship. These didactic lectures will feature mentoring experts sharing their experiences in how to receive, provide, and optimize mentoring. Mentor/Mentee relationships can be hard to foster, and in this session, we will focus on empowering junior faculty with the tools to get the most out of this relationship. Junior faculty will hear from mentors and mentees both in the clinical and basic research fields and gain a better understanding on what it is to be a good mentor and mentee.
Co-Chairs:
Adam ScottÌýKittai,ÌýMD
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Andrew GÌýVolk,ÌýPhD
Cincinnati Children's Hospital Medical Center
°ä¾±²Ô³¦¾±²Ô²Ô²¹³Ù¾±,Ìý°¿±á
Speakers:
Betty S.ÌýPace,ÌýMD
Augusta University
´¡³Ü²µ³Ü²õ³Ù²¹,Ìý³Ò´¡
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?
Adam ScottÌýKittai,ÌýMD
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?
JosephÌýMikhael,ÌýMD, MeD, FRCPC, FACP
Translational Genomics Research Institute
±Ê³ó´Ç±ð²Ô¾±³æ,Ìý´¡´Ü
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it
³§³ó²¹²Ô²Ô´Ç²ÔÌý·¡±ô´Ú,Ìý±Ê³ó¶Ù
The University of Chicago
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it
Leidy L.ÌýIsenalumhe,ÌýMD, MS
Moffitt Cancer Center
³¢³Ü³Ù³ú,Ìý¹ó³¢
Transitioning from Being a Mentee to Becoming a Mentor
RaquelÌýEspin Palazon,ÌýPhD
Iowa State University
´¡³¾±ð²õ,Ìý±õ´¡
Transitioning from Being a Mentee to Becoming a Mentor
Grassroots Network Lunch
Saturday, DecemberÌý7,Ìý2024,Ìý11:15Ìýa.m.Ìý-Ìý12:15Ìýp.m.
Marriott Marquis San Diego Marina, Marina Ballroom DE
The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress and their elected officials, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. An overview of the Society’s 2024 advocacy accomplishments and a preview of the Society’s 2025 advocacy agenda will also be provided.
Co-Chairs:
Jennifer LÌýHolter-Chakrabarty,ÌýMD
University of Oklahoma Stephenson Cancer Center
Oklahoma City,ÌýOK
Bart L.ÌýScott,ÌýMD
Fred Hutchinson Cancer Center
³§±ð²¹³Ù³Ù±ô±ð,Ìý°Â´¡
Speaker:
KirkÌýBado,ÌýBelmont University, Bachelor of Science in Politics and Public Law. University of North Carolina, Masters of Communication
National Journal
°Â²¹²õ³ó¾±²Ô²µ³Ù´Ç²Ô,Ìý¶Ù°ä
Grassroots Network Lunch
Health Equity Rounds Lunch
Sunday, DecemberÌý8,Ìý2024,Ìý11:30Ìýa.m.Ìý-Ìý12:30Ìýp.m.
Manchester Grand Hyatt San Diego, Coronado Ballroom AB
Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.
Co-Chairs:
Yvonne A.ÌýEfebera,ÌýMD
Ohio Health
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
³§°ù¾±²Ô¾±±¹²¹²õÌý¶Ù±ð±¹²¹°ù²¹°ì´Ç²Ô»å²¹,Ìý²Ñ¶Ù
Ohio State University Medical Center
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Speakers:
Ash BlytheÌýAlpert,ÌýMD, MFA
Yale School of Medicine
New Haven,ÌýCT
Hematologic Aspects of Gender Affirming Care
Eric ScottÌýMullins,ÌýMD
Cincinnati Children's Hospital Medical Center
°ä¾±²Ô³¦¾±²Ô²Ô²¹³Ù¾±,Ìý°¿±á
Hematologic Aspects of Gender Affirming Care
Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology
Sunday, DecemberÌý8,Ìý2024,Ìý9:30Ìýa.m.Ìý-Ìý11:00Ìýa.m.
San Diego Convention Center, Room 6DE
The misuse of race in medicine has far-reaching implications across practice, teaching, and research in hematology. This session is intended to explore what race is and what it is not, and illustrate how systemic factors, including racism, influence health care access and outcomes. The session will also explore strategies to tackle systemic racism in patient care and how to create conditions for equitable care for patients with blood diseases. Dr. Joseph L. Graves Jr. will provide a summary of the history of biological conceptions of race and describe modern evolutionary conceptions of race. He will then address how this understanding can be useful in employing the power of modern genomic tools applied to human biological diversity, including how the use of these tools completely unravels the false premises of racial medicine. Dr. Chanita Hughes Halbert will define health care disparities and describe the nature and distribution of social determinants of disparities in disease risk and outcomes. She will also provide an overview of structural racism and its impact on health care outcomes in diverse populations.
Chair:
Deirdra RÌýTerrell,ÌýPhD
University of Oklahoma Health Sciences Center
Oklahoma City,ÌýOK
Speakers:
Joseph LÌýGraves Jr.,ÌýPhD
North Carolina A&T State University
³Ò°ù±ð±ð²Ô²õ²ú´Ç°ù´Ç,Ìý±·°ä
The Myth of Race in Medical Science
Chanita HughesÌýHalbert,ÌýPhD
University of Southern California
Los Angeles,ÌýCA
Structural Racism, the Social Determinants of Health, and Healthcare Outcomes – Understanding Inequity and What to Do About It
Hematology Inclusion Pathway (HIP) Networking Reception
Saturday, DecemberÌý7,Ìý2024,Ìý8:00Ìýp.m.Ìý-Ìý9:00Ìýp.m.
Marriott Marquis San Diego Marina, Marina Ballroom G
Join our HIP community to network and celebrate our awardees and their mentors at this reception following the oral presentations.Ìý
back to topHematology Inclusion Pathway (HIP) Oral Presentations - Classical Hematology
Saturday, DecemberÌý7,Ìý2024,Ìý6:00Ìýp.m.Ìý-Ìý9:00Ìýp.m.
Marriott Marquis San Diego Marina, Marina Ballroom E
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.Ìý
Moderators:
CeceliaÌýCalhoun,ÌýMD,MBA,MPH
Yale School of Medicine
New Haven,ÌýCT
Dailia B.ÌýFrancis,ÌýMD,PhD
Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta
´¡³Ù±ô²¹²Ô³Ù²¹,Ìý³Ò´¡
Imo J.ÌýAkpan,ÌýMD
Columbia University
New York,ÌýNY
Speakers:
ValeriaÌýBrown
The Warren Alpert Medical School of Brown University
Providence,ÌýRI
Investigating the Role of Long Interspersed Element-1 (LINE-1) in Age-Related Clonal Hematopoiesis of Indeterminate Potential (CHIP) Driven By JAK2 V617F Mutation
Esther ChiomaÌýEmenalom
University of California, San Diego
San Diego,ÌýCA
A Study of Postpartum Hemorrhage and a Cryoprecipitate Intervention at Hospital Central De Maputo
Maria FernandaÌýAlbuja Altamirano,ÌýMD
Lincoln General Hospital
New York,ÌýNY
Incidence of Thrombotic and Bleeding Complications in Patients with Cancer Undergoing Lower Extremity Arthroplasty, an Administrative Database Study
AshleyÌýCrosby,ÌýMD
Atrium Health Wake Forest Baptist Medical Center
Winston Salem,ÌýNC
Monocyte Distribution Width As a Marker of Red Cell Alloimmunization
Ayotola A.ÌýFatola,ÌýMD
Johns Hopkins University School of Medicine
µþ²¹±ô³Ù¾±³¾´Ç°ù±ð,Ìý²Ñ¶Ù
Evaluating the Role of Voxelotor and Percent Modified Hemoglobin (Hemoglobin X) on Laboratory and Clinical Responses in Patients with Sickle Cell Disease
OlisaemekaÌýOgbue,ÌýMBBS
Cleveland Clinic Foundation
Rocky River,ÌýOH
Can Emergency Hematopoiesis Due to Sepsis Lead to Clonal Hematopoiesis? Implications for Understanding the Pathogenesis of Clonal Evolution
MariaÌýFeliz Norberto,ÌýMS
Albert Einstein College of Medicine
Bronx,ÌýNY
Heterozygous DDX41 Mutations Promote Age-Dependent Hematopoietic Stem and Progenitor Dysfunction
Conroy OÌýField,ÌýMS
The University of Pennsylvania School of Medicine
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Role of Platelet Factor 4 in the Prothrombotic Nature of Antiphospholipid Syndrome
SarahÌýMansour
Emory University
´¡³Ù±ô²¹²Ô³Ù²¹,Ìý³Ò´¡
Methionine Sulfoxide and Other Metabolites from Bronchoalveolar Lavage Are Associated with Neutrophil-Dominated Lung Disease in Early Cystic Fibrosis
Olufunke Y.ÌýMartin,ÌýMD
Children's National Hospital
Washington DC,ÌýDC
The Role of Red Blood Cell Vascular Adhesion Biomarkers in Understanding Sickle Cell Disease-Associated Chronic Pain
Walatta-TseyonÌýMesquitta,ÌýBSc,DPhil
Boston Children's Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Interrogating TCF15 Function in Native Hematopoiesis Using TCF15 Overexpression and Conditional Knock out Mouse Models
Hematology Inclusion Pathway (HIP) Oral Presentations - Health Services Outcomes
Saturday, DecemberÌý7,Ìý2024,Ìý6:00Ìýp.m.Ìý-Ìý9:00Ìýp.m.
Marriott Marquis San Diego Marina, Marina Ballroom F
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.Ìý
Moderators:
JoannaÌýRobles,ÌýMD
Atrium Health Wake Forest Baptist Brenner Children’s Hospital
Winston Salem,ÌýNC
Oreofe O.ÌýOdejide,ÌýMD,MPH
Dana-Farber Cancer Institute
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Staci D.ÌýArnold,ÌýMD, MBA, MPH
Aflac Canver and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University
Atlanta,Ìý
Speakers:
EmilyÌýFranco,ÌýBA
The Warren Alpert Medical School of Brown University
Davie,ÌýFL
Exploring Mental Health in Sickle Cell Disease: Implementing Routine Psychological Assessment in a Comprehensive Sickle Cell Clinic
RachelleÌýMonteau
CUNY School of Medicine
New York,ÌýNY
Outcomes of Adult ALL/LBL Patients from Diverse Backgrounds Treated in the United States between 2000 and 2022
OsariemenÌýOgiamien
University of California Riverside Science Library
Riverside,ÌýCA
Neighborhood Socioeconomic/Environmental Disadvantage and Health Outcomes after Allogeneic Hematopoietic Cell Transplantation
MargaritaÌýVazquez Almonte
SUNY Upstate Medical University
Bronx,ÌýNY
Parenthood While in Hematology: Perceived Barriers
DanielÌýGoyco Vera,ÌýMD
Baylor College of Medicine
±á´Ç³Ü²õ³Ù´Ç²Ô,Ìý°Õ³Ý
Outcomes of Patients Underrepresented in Pivotal Trials of CAR-T Cell Therapy
MichelleÌýNwachukwu,ÌýDO
University of Illinois at Chicago
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
The Impact of Structural Racism on Molecular Subtypes and Survival Outcomes in Acute Myeloid Leukemia Patients
Ifeanyi NnamdiÌýUche,ÌýMBBS
One Brookdale University Hospital and Medical Center
Brooklyn,ÌýNY
Examining the Impact of Body Mass Index on Outcomes in Young Adults with Sickle Cell Disease: A Single-Center Study
BritneyÌýBell,ÌýMD
Section of Hematology and Medical Oncology, Boston Medical Center
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Integration of Health Literacy Universal Precautions into Clinical Practice as a Strategy to Improve Patient-Reported Outcomes in Patients with Hematologic Malignancies and Limited English Proficiency
Eden AyeleÌýBiltibo,ÌýMD,MS
Vanderbilt University Medical Center
Nashville,ÌýTN
Impact of Daratumumab in the Treatment of Vulnerable Transplant Eligible Multiple Myeloma Patients and Its Utilization in Blacks
GerardÌýHills,ÌýMD
Riley Hospital for Children at Indiana University Health
Indianapolis,ÌýIN
A Step Toward Individualized Mortality Risk Prediction in Patients with Sickle Cell Disease in a National EHR-Derived Population Dataset
AlexandraÌýPower-Hays,ÌýMD
Cincinnati Children's Hospital Medical Center
°ä¾±²Ô³¦¾±²Ô²Ô²¹³Ù¾±,Ìý°¿±á
Alternative Dosing and Prevention of Transfusions (ADAPT): A Prospective Trial to Quantify the Change in Blood Transfusion Use with Hydroxyurea Treatment and the Feasibility of Pharmacokinetic-Guided Dosing in Children with Sickle Cell Anemia in Uganda
Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology
Saturday, DecemberÌý7,Ìý2024,Ìý6:00Ìýp.m.Ìý-Ìý9:00Ìýp.m.
Marriott Marquis San Diego Marina, Marina Ballroom D
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.
Moderators:
AnitaÌýD'Souza,ÌýMD
Medical College of Wisconsin
²Ñ¾±±ô·É²¹³Ü°ì±ð±ð,Ìý°Â±õ
JorgeÌýMonge,ÌýMD
University of Colorado Anschutz Medical Campus
Aurora,ÌýCO
MazieÌýTsang,ÌýMD
Mayo Clinic
±Ê³ó´Ç±ð²Ô¾±³æ,Ìý´¡´Ü
Speakers:
John Roy RÌýLozada,ÌýMD
University of Minnesota
Minneapolis,ÌýMN
An Integrated Systems Biology Approach to Understanding the Phenotypic and Functional Diversity of Natural Killer Cells in Cancer
Sofia E.ÌýLuna
Leland Stanford Stanford Junior University
³§³Ù²¹²Ô´Ú´Ç°ù»å,Ìý°ä´¡
Engineering Hematopoietic Stem Cells to Generate Therapeutic Antibody Secreting B Cells
FathimaÌýMohamed
University of Minnesota
Minneapolis,ÌýMN
Metabolic Regulation of the Germinal Center Reaction in Chronic Graft Versus Host Disease
Andres JÌýRubio,ÌýMS
Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine
El Paso,ÌýTX
A Role for PSMD3 in Regulating Oxidative Energy Metabolism in Acute Myeloid Leukemia (AML)
CatherineÌýGutierrez,ÌýMD, PhD
Massachusetts General Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Identifying Mechanisms of Resistance to ATR Inhibition in Myelodysplastic Syndromes with Splicing Factor Mutations
KellyÌýMeza,ÌýMD
Baylor College of Medicine
±á´Ç³Ü²õ³Ù´Ç²Ô,Ìý°Õ³Ý
Retrospective Analysis of the PET/CT Imaging Features of Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL) Patients
JoaneÌýTitus,ÌýMD, MS
University of Central Florida
Orlando,ÌýFL
Retrospective Review of Care for Black/African American Veterans with Multiple Myeloma at the Orlando VA
KalayÌýBertulfo,ÌýMS,MA,MPhil
Columbia University Irving Medical Center
New York,ÌýNY
Therapeutic Targeting of JAK/STAT Signaling and Histone Acetyltransferase Activity in Post-Myeloproliferative Neoplasm Secondary AML
QuentonÌýBubb,ÌýMPhil
Leland Stanford Junior University
³§³Ù²¹²Ô´Ú´Ç°ù»å,Ìý°ä´¡
Development of Multivalent Cell Therapies for Treatment of Hematologic Malignancies
JoiceÌýKanefsky
Fox Chase Cancer Center
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Disruption of Polyunsaturated Fatty Acid Biosynthesis Drives Sting-Dependent Acute Myeloid Leukemia Cell Maturation and Death
Kristopher AdrianÌýKnight
Emory University
´¡³Ù±ô²¹²Ô³Ù²¹,Ìý³Ò´¡
Development of a Novel L-Asparaginase with Enhanced Properties Using Ancestral Sequence Reconstruction
OwhofasaÌýAgbedia
MD Anderson Cancer Center
houston,ÌýTX
Targeting Aggressive NK-Cell Leukemia and Other CD94-Expressing NK/T-Cell Lymphoproliferative Disorders with CAR T-Cell Therapy
LGBTQIA+ Community Networking Brunch (for in-person participants)
Sunday, DecemberÌý8,Ìý2024,Ìý11:00Ìýa.m.Ìý-Ìý12:30Ìýp.m.
Manchester Grand Hyatt San Diego, Coronado DE
This is a community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create a sense of belonging and allyship. This year’s event will include an insightful panel discussion focused on being LGBTQIA+ across the hematology career spectrum, including the role of mentorship and the importance of inclusivity, as well as ample networking opportunities.
Moderator:
JonasÌýJutzi,ÌýMD, PhD
Brigham and Women’s Hospital, Harvard Medical School
Boston,Ìý
Panelists:
Mouhamed YazanÌýAbou-Ismail,ÌýMD
University of Utah
Salt Lake City,ÌýUT
DianeÌýKrause
Yale University
New Haven,ÌýCT
CristianÌýTaborda,ÌýMD
Yale University School of Medicine
New Haven,ÌýCT
Medical Educators Symposium
Sunday, DecemberÌý8,Ìý2024,Ìý7:30Ìýa.m.Ìý-Ìý9:30Ìýa.m.
Marriott Marquis San Diego Marina, Marina Ballroom FG
The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with an hour of general sessions focused on medical education principles and then followed by simultaneous breakout sessions that happen twice.
Chair:
Hetty E.ÌýCarraway,ÌýMD,MBA
Cleveland Clinic
Cleveland,ÌýOH
Speakers:
Alison WÌýLoren,ÌýMD
University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
General Session 1: Paving a Career in Medical Education & Scholarship
Megan MurrayÌýDupuis,ÌýMD, PhD
Vanderbilt University Medical Center
Nashville,ÌýTN
General Session 2: Utilizing Humanities to Influence and Tailor Hematology Curriculum for Adult Learners
Layla NÌýVan Doren,ÌýMD, MBA
Yale University
New York,ÌýNY
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum
Alexander AÌýBoucher,ÌýMD
University of Minnesota
Minneapolis,ÌýMN
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum
BeverlyÌýSchaefer,ÌýMD
University of Buffalo
Buffalo,ÌýNY
Breakout 1: Challenges of Course Development
Ariela L.ÌýMarshall,ÌýMD
University of Minnesota
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Breakout 2: Developing Your Teaching Portfolio
Jason AÌýFreed,ÌýMD
Beth Israel Deaconess
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Breakout 3: Cutting-Edge Technology in Education Delivery
Thomas W.ÌýLeBlanc,ÌýMD,MA,MS
Duke Cancer Institute
Hillsborough,ÌýNC
Breakout 4: Developing a Palliative Care/Difficult Discussion Curriculum
Race and Ancestry in Precision Medicine
Sunday, DecemberÌý8,Ìý2024,Ìý4:30Ìýp.m.Ìý-Ìý5:45Ìýp.m.
San Diego Convention Center, Room 6DE
Race and ancestry, historically, have been poorly considered in basic and translational research design and clinical diagnoses. This session will describe how race and ancestry can inform hematology research conduct, specifically in clinical and genetic population profiling, interpretation of common hematologic tests, development of diagnostics, and overall precision medicine. The speakers selected in this session have incorporated race and ancestry in their own research and will be sharing their insights to help educate hematology investigators and clinicians understand how to consider race and ancestry into their own research and practice.
Dr. Fox will discuss the intersection between human population genetics, biomedicine, ancient genomics, and Indigenous data sovereignty. This talk will provide perspectives on why community consultation matters in genomics research and in the establishment of benefit-sharing models.
Dr. Eisfeld will discuss race-associated differences in the mutational landscape and the prognostic significance of molecular markers in acute myeloid leukemia (AML) in Black patients. This talk will highlight the need for refinement of disease classification and molecular subtypes to enable personalized risk-stratification and treatment options for racially diverse populations.
Dr. Achebe has led the hematology community in incorporating Duffy-null status into clinical algorithms to improve health equity for Duffy-null individuals among Black and African American adults. This talk will highlight how inappropriate blood count reference ranges can propagate systemic racism.
Co-Chairs:
Jennifer J.ÌýTrowbridge,ÌýPhD
The Jackson Laboratory
Bar Harbor,ÌýME
Sant-RaynÌýPasricha,ÌýMD,PhD
Walter and Eliza Hall Institute of Medical Research
Fitzroy North,ÌýVIC,ÌýAustralia
Speakers:
KeoluÌýFox
University of California, San Diego
San Diego,ÌýCA
Incorporating Indigenous Perspectives into Population Genetics
Ann-KathrinÌýEisfeld,ÌýMD
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Risk Re-Stratification Based on Black AML Patient Exome Data
Maureen OkamÌýAchebe,ÌýMD,MPH
Brigham and Women's Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
How Inappropriate Reference Ranges Can Propagate Systemic Racism
Sickle Cell Disease Centers Session
The Role of Quality Metrics in Demonstrating Value of Your Sickle Cell Disease Center
Sunday, DecemberÌý8,Ìý2024,Ìý9:30Ìýa.m.Ìý-Ìý11:00Ìýa.m.
San Diego Convention Center, Room 33
To ensure high-quality care for patients with sickle cell disease (SCD), it is imperative that providers and SCD care leaders have the tools to establish comprehensive clinical care centers for patients with SCD. Over the last several years, ASH has developed a program and blueprint for the creation of sickle cell disease centers. This special interest session is designed to help sickle cell disease care centers understand the development of CMS quality metrics and how to leverage these metrics to support delivery of high-quality care.
Co-Chairs:
³§´Ç±è³ó¾±±ðÌý³¢²¹²Ô³ú°ì°ù´Ç²Ô,Ìý²Ñ¶Ù
Sidney Kimmel College of Medicine, Thomas Jefferson University
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
CeceliaÌýCalhoun,ÌýMD,MBA,MPH
Yale New Haven Hospital
New Haven,ÌýCT
Speakers:
AlexandraÌýPower-Hays,ÌýMD
Cincinnati Children's Hospital
°ä¾±²Ô³¦¾±²Ô²Ô²¹³Ù¾±,Ìý°¿±á
The Importance of Recognition of Pediatric Quality Metrics in SCD: The Role of US News and World Report
TitilopeÌýFasipe,ÌýMD,PhD
Texas Children's Cancer and Hematology Centers
±á´Ç³Ü²õ³Ù´Ç²Ô,Ìý°Õ³Ý
The Creation of CMS Quality Metrics in the Treatment of Painful Episodes in the Emergency Department
CeceliaÌýCalhoun,ÌýMD,MBA,MPH
Yale New Haven Hospital
New Haven,ÌýCT
Leveraging Quality Metrics to Maintain Support of Your Sickle Cell Disease Center
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Sunday, DecemberÌý8,Ìý2024,Ìý1:30Ìýp.m.Ìý-Ìý4:00Ìýp.m.
San Diego Convention Center, Room 6A
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Sunday, DecemberÌý8,Ìý2024,Ìý1:30Ìýp.m.Ìý-Ìý4:00Ìýp.m.
San Diego Convention Center, Room 28 A-D
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Sunday, DecemberÌý8,Ìý2024,Ìý1:30Ìýp.m.Ìý-Ìý4:00Ìýp.m.
Marriott Marquis San Diego Marina, San Diego Ballroom AB
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Sunday, DecemberÌý8,Ìý2024,Ìý1:30Ìýp.m.Ìý-Ìý4:00Ìýp.m.
Manchester Grand Hyatt San Diego, Grand Hall B
Symposium for Mid-Career Hematologists
Sunday, DecemberÌý8,Ìý2024,Ìý4:30Ìýp.m.Ìý-Ìý6:00Ìýp.m.
San Diego Convention Center, Room 24
This symposium aims to guide the audience through the common challenges faced by mid-career hematologists. Some examples of unique challenges for mid-career hematologists include negotiating the first leadership position, principles of leadership, promotion, strategies for managing individuals and teams, conflict management, setting up a successful research program, time management, funding beyond career development awards, performance and compensation metrics, self-care and opportunities to contribute to the Society’s mission. Speakers will include a diverse pool of successful physicians and scientists from academia, regulatory agencies, and the pharmaceutical industry. It is envisioned that this educational session will be organized by a steering committee of Society members who will identify a longitudinal curriculum for the session and speakers and topics.
Chairs:
Juan PabloÌýAlderuccio,ÌýMD
Sylvester Comprehensive Cancer Center University of Miami
Miami,ÌýFL
ShrutiÌýChaturvedi,ÌýMBBS
Johns Hopkins University
µþ²¹±ô³Ù¾±³¾´Ç°ù±ð,Ìý²Ñ¶Ù
Speakers:
Ruben A.ÌýMesa,ÌýMD
Atrium Health Wake Forest Baptist
Winston-Salem,ÌýNC
Negotiating Your First Leadership Position
Allison A.ÌýKing,ÌýMD,PhD,MPH
Washington University School of Medicine
Saint Louis,ÌýMO
Negotiating Your First Leadership Position
Robert F.ÌýSidonio, Jr.,ÌýMD, MSc
Emory University
´¡³Ù±ô²¹²Ô³Ù²¹,Ìý³Ò´¡
Your Next Job - How to Identify Academic Opportunities with the Best Payback
Jeffrey DÌýLebensburger,ÌýDO
University of Alabama at Birmingham
µþ¾±°ù³¾¾±²Ô²µ³ó²¹³¾,Ìý´¡³¢
Your Next Job - How to Identify Academic Opportunities with the Best Payback
NinaÌýShah,ÌýMD
AstraZeneca
South San Francisco,ÌýCA
Making the Jump - Careers Outside Academia
David P.ÌýSteensma,ÌýMD
Ajax Therapeutics
Cambridge,ÌýMA
Making the Jump - Careers Outside Academia
Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities
Saturday, DecemberÌý7,Ìý2024,Ìý2:00Ìýp.m.Ìý-Ìý3:30Ìýp.m.
San Diego Convention Center, Room 11
This year's Quality Symposium will focus on practical strategies for combatting healthcare disparities. First, Dr. Melissa Creary will discuss the Michigan Social Health Interventions to Eliminate Disparities (MSHIELD) program, a statewide data-driven, community-partnered, and equity-centered quality improvement effort. Then Dr. Michelle Sholzberg will review the development and impact of the "Raise the Bar" project, which aims to eliminate disparities in the recognition and management of iron deficiency by adjusting reference ranges. The session will conclude with a talk by Dr. Thomas Greg Knight on mitigating the impact of financial toxicity in patients with hematologic malignancies.
Co-Chairs:
Angela CÌýWeyand,ÌýMD
University of Michigan
Ann Arbor,ÌýMI
AdamÌýCuker,ÌýMD, MS
University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Speakers:
MelissaÌýCreary
University of Michigan School of Public Health
Ann Arbor,ÌýMI
MSHIELD:Ìý A Statewide Approach to Improving Equity Centered Quality Improvement
MichelleÌýSholzberg,ÌýMDCM, MSc
University of Toronto
°Õ´Ç°ù´Ç²Ô³Ù´Ç,Ìý°¿±·,Ìý°ä²¹²Ô²¹»å²¹
Raise the Bar - Combatting Disparities in the Recognition and Management of Iron Deficiency
Thomas G.ÌýKnight,ÌýMD
Atrium Health
Charlotte,ÌýNC
Cancer and Poverty - Mitigating the Impact of Financial Toxicity in Patients with Hematologic Malignancies
Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management
Sunday, DecemberÌý8,Ìý2024,Ìý4:30Ìýp.m.Ìý-Ìý6:30Ìýp.m.
San Diego Convention Center, Room 25
This session will feature two talks on systems-level approaches to anticoagulation management, followed by a networking session where attendees will meet with the speakers and with established systems-based hematologists over light hors d'oeuvres and drinks. The first talk with feature Dr. Greg Barnes discussing how to improve systems-level management of anticoagulants within and across care settings. For the second talk, Dr. Damon E. Houghton will discuss the use of artificial intelligence (AI) and machine learning (ML) in the context of anticoagulation management.
Chair:
CamilaÌýMasias,ÌýMD,MPH
Miami Cancer Institute
Miami,ÌýFL
Speakers:
Geoffrey DÌýBarnes,ÌýMD, MSc
University of Michigan
Ann Arbor,ÌýMI
Improving Systems-Level Management of Anticoagulants Within and Across Care Settings
Damon E.ÌýHoughton,ÌýMD,MS
Mayo Clinic Rochester
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Artificial Intelligence (AI) and Machine Learning (ML) in the Context of Anticoagulation Management
Training Program Directors Workshop
Friday, DecemberÌý6,Ìý2024,Ìý9:00Ìýa.m.Ìý-Ìý12:00Ìýp.m.
Hilton San Diego Bayfront, Indigo 204
The Training Program Director’s Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training. The workshop is designed for hematology program directors to share lessons learned, best practice, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network. At this year’s TPDW, we will focus on three opportune topics. First, we will discuss how to design and implement innovative curriculums which can prepare trainees to excel at various aspects of hematology oncology practice beyond just knowledge of the subject matter. Examples of such curriculums include ‘leadership training’, ‘how to be a good educator’, and ‘business of hematology-oncology’. Second, we will focus on best practices for a training program to leverage social media and build their ‘brand’. Lastly, we will discuss practical ways in which programs can help trainees land their dream job.
Chair:
PallawiÌýTorka
Roswell Park Cancer Center
Buffalo,ÌýNY
Speakers:
ScottÌýMoerdler,ÌýMD
Rutgers Cancer Institute
New Brunswick,ÌýNJ
Innovative Fellowship Curriculum
Layla NÌýVan Doren,ÌýMD, MBA
Yale School of Medicine
New Haven,ÌýCT
Innovative Fellowship Curriculum
Angela CÌýWeyand,ÌýMD
University of Michigan
Ann Arbor,ÌýMI
Leveraging and Enriching Social Media
GeraldÌýHsu,ÌýMD,PhD
University of California, San Francisco
San Francisco,ÌýCA
Best Practices to Support Fellows in the Job Search
SunandanaÌýChandra,ÌýMD
Northwestern University
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
Best Practices to Support Fellows in the Job Search
Women In Hematology Networking Event (for in-person participants)
Monday, DecemberÌý9,Ìý2024,Ìý7:30Ìýp.m.Ìý-Ìý9:30Ìýp.m.
Manchester Grand Hyatt San Diego, Coronado Ballroom and Terrace
This popular annual networking event will provide a space where all can gather and connect with peers and potential mentors. The event includes a panel discussion focused on work life integration through a gender and career development lens. Hors d'oeuvres will be provided before and after the panel, along with desserts after the panel.
Ìý
Moderators:
BethanyÌýSamuelson Bannow,ÌýMD
Oregon Health and Science University
Portland,ÌýOR
GlaivyÌýBatsuli,ÌýMD
Stanford University
³§³Ù²¹²Ô´Ú´Ç°ù»å,Ìý°ä´¡
66th ASH Annual Meeting and exposition
Registration for ASH members, non-members, groups, exhibitors, and media is now open!